Prognostic relevance of FLT3-TKD mutations in AML: the combination matters—an analysis of 3082 patientsUlrike Bacher(Universität Hamburg), Susanne Schnittger(Munich Leukemia Laboratory (Germany))BloodOctober 26, 200710.1182/blood-2007-05-091215Cited by 410SaveCiteExport RISWatch citationsRelated PapersNucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype|Blood|2005|703